Don't let a DVT put an end to your dream holiday.
Veno-Fast Capsules are formulated to keep blood flow healthy and arterial walls flexible to avoid and prevent the chances of deep vein thrombosis.
Veno-Fast contains the following:
Rutin is a citrus flavonoid glycoside. Studies indicate that this flavonoid acts on blood vessel health, positively affecting varicose veins, superficial venous insufficiency, and venous ulcers. Rutins improve circulation, strengthen capillaries, reduce inflammation, and improve venous edema.
Horse Chestnut Extract
Horse chestnut extract, the common name for aesculus hippocastanum, is used for treating chronic venous insufficiency. It is an anti-inflammatory herb that promotes normal tone of the vein wall, thereby improving circulation through the veins. Benefits can include reduced leakage of the capillaries and a reduction in lower leg swelling.
Gotu kola is used in the treatment of venous insufficiency and the healing of wounds. Gotu kola stimulates the production of collagen, a protein found in the fibrous tissue of blood vessels. Studies have reported its effectiveness in healing vein walls and tissues. Its benefits include reduced swelling and improved circulation and vascular tone.
Butcher's broom is recognized for its positive effect on blood flow. Recently, European interest in the herb has focused on its potential for treatment of varicose veins, and it has been approved by Germany's regulatory commission for herbal therapies as a treatment for chronic venous insufficiency. Research conducted with butcher's broom has shown decreases in leg swelling, pointing toward its efficacy.
Bilberry contains potent antioxidants called anthocyanosides, which strengthen blood vessels and capillary walls and improve red blood cells. Bilberry supplements are used to prevent and treat circulation problems, including chronic venous insufficiency. Bilberry fruit are also antiangiogenic, meaning they can reduce the growth of blood vessels that may lead to varicose veins.
Varicose veins and spider veins have excess amounts of fibrin, a fibrous protein that promotes the clotting of blood. Bromelain can break down fibrin and promote better circulation. Helps treat chronic venous insufficiency and may prevent the swelling and soreness caused by varicose veins.
Pine Bark Extract
Pine bark extract is extracted from the inner bark of certain European pine trees and contain the antioxidants oligomeric proanthocyanidin compounds (OPCs). The OPCs in pine bark extract bind to the collagen in blood vessel walls making blood vessels stronger and more elastic, which subsequently improves circulation. It has anti-inflammatory effects, and has been shown to reduce symptoms of chronic inflammation, a contributor to venous insufficiency. It can also reduce leg and ankle edema. The extract has been widely studied for the past 40 years and has many published studies and review articles ensuring its safety and efficacy. A recent study in the International Journal of Angiology suggests that pine bark extract may significantly improve the appearance, swelling and discomfort of pregnancy-induced varicose veins and spider veins.
Hawthorne contains anti-oxidants such as quercetin and OPC’s (oligomeric procyandins). Hawthorne dilates blood vessels, protects blood vessels and improves blood flow. Hawthorne avoids damage to blood vessels.
Deep Vein Thrombosis
Venous thromboembolism (VTE) is the formation of blood clots in the vein. When a clot forms in a deep vein, usually in the leg, it is called a deep vein thrombosis or DVT. If that clot breaks loose and travels to the lungs, it is called a pulmonary embolism or PE. Together, DVT and PE are known as VTE - a dangerous and potentially deadly medical condition.
Deep vein thrombosis (DVT) - A blood clot that forms in a deep vein (usually in the leg).
Pulmonary embolism (PE) - A blood clot in the lungs. PE occurs when a DVT breaks free from a vein wall, travels to the lungs and blocks some or all of the blood supply to the lungs. PE can often be fatal.
DVT + PE = VTE - DVT and PE are collectively referred to as VTE.
VTE is a leading cause of death and disability worldwide. A comprehensive scientific review by the WTD steering committee revealed that 10 million cases of VTE occur annually – across low, middle and high income countries. Yet, VTE-related death is largely undocumented with data predominantly confined to Europe and the United States. Read more about the findings.
Just as concerning is that many people are not aware of this condition. A survey conducted by WTD and Ipsos-Reid found that global public awareness of thrombosis, DVT and PE is low, and much lower than awareness of other conditions like heart attack, stroke, hypertension, breast cancer, prostate cancer and AIDS. And, less than half of adults know that blood clots can be prevented.
FACTS AND FIGURES
Every year, there are approximately 10 million cases of VTE worldwide.
In the U.S., there are 100,000 - 300,000 VTE-related deaths every year.
In Europe, there are 544,000 VTE-related deaths every year.
In the U.S. and Europe, VTE-related events kill more people than AIDS, breast cancer, prostate cancer and motor vehicle crashes combined.
Up to 60 percent of VTE cases occur during or after hospitalization, making it a leading preventable cause of hospital death.
VTE does not discriminate. It affects people of all ages, races and ethnicities, and occurs in both men and women. Certain factors and situations can increase the risk of developing potentially deadly blood clots.
Being in the hospital for an extended period of time
Having surgery (especially hip, knee and cancer-related surgery)
Not moving for long periods of time (e.g., due to bedrest or long-duration travel)
Personal or family history of blood clots
Using estrogen-based medication (e.g., oral contraceptives or hormone replacement therapy)
Pregnancy or recent birth
WARNING SIGNS AND SYMPTOMS
VTE can occur without any warning signs or symptoms and can go unrecognized and undiagnosed by a healthcare professional. Symptoms that do appear may be associated with either DVT or PE.
DEEP VEIN THROMBOSIS (DVT)
Pain or tenderness, often starting in the calf
Swelling, including the ankle or foot
Redness or noticeable discoloration
PULMONARY EMBOLISM (PE)
Unexplained shortness of breath
Chest pain (may be worse upon deep breath)
Rapid heart rate
Light headedness or passing out
Research suggests that VTEs are often preventable, and evidence-based prevention strategies can stop the development of clots in 'at-risk' individuals.
To identify whether a patient is 'at-risk,' healthcare professionals should conduct a VTE risk assessment, which is tool or questionnaire that gathers information about a patient's age, medical history, medications and specific lifestyle factors. Information is then used to discern a patient’s potential risk (e.g., high, moderate or low risk) for developing blood clots in the legs or lungs.